CardioLogs ECG Analysis Platform vs Study Watch

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by Verily

AI Verdict

Tool A is an AI-powered platform designed to analyze ECG data from various cardiac monitoring devices to assist physicians in arrhythmia diagnosis. Tool B is a wearable device for continuous physiological monitoring, primarily for clinical research, which collects its own ECG data for cloud-based analysis. While both leverage AI for cardiac insights and involve ECG data, Tool A focuses on analyzing existing data for clinical diagnosis, whereas Tool B is a data collection device for research purposes.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your clinical practice requires a highly efficient and accurate solution for diagnosing arrhythmias from a variety of ECG monitoring devices. This platform is ideal for cardiologists and emergency medicine physicians needing rapid, AI-powered analysis of high volumes of ECG data, streamlining diagnostic workflows and integrating with existing EHR systems.

View CardioLogs ECG Analysis Platform →

Choose Study Watch if…

Choose Verily Study Watch if your clinical research study demands continuous, multi-parameter physiological monitoring from participants over extended periods. This prescription-only wearable is specifically designed for research, providing reliable data collection for ECG, heart rate, and movement, which is then processed in Verily's secure cloud platform for in-depth analysis in clinical trials or observational studies.

View Study Watch →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform Study Watch
Deployment Cloud-based The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub).
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CardioLogs ECG Analysis Platform

CardioLogs ECG Analysis Platform is designed for direct clinical diagnostic use, featuring EHR integration, customizable reports, and an ergonomic user interface to streamline the physician's workflow for rapid and efficient ECG analysis. In contrast, while Verily Study Watch has patient-facing usability for data collection, its clinician-facing web portal is limited to viewing data without analysis features, making its direct clinical diagnostic usability less comprehensive.

Clinical Value

CardioLogs ECG Analysis Platform

CardioLogs directly aids physicians in arrhythmia detection and diagnosis through medical-grade AI, demonstrating improved accuracy and efficiency in identifying conditions like AFib and VT, and was the first FDA-cleared AI solution for ECG analysis. Verily Study Watch, while FDA-cleared for an irregular pulse monitor for AFib, primarily functions as a data collection device for clinical research, with its clinician portal offering viewing capabilities but no direct diagnostic analysis.

Pricing & Value

CardioLogs ECG Analysis Platform

CardioLogs offers a transparent, usage-based pricing model ('Pay per ECG'), allowing healthcare providers to clearly understand and budget for its cost based on their volume of ECGs. Verily Study Watch's pricing is not publicly available and is geared towards clinical research and partnerships, making it difficult to assess its value for general clinical use in a typical healthcare setting.

Enterprise Readiness

CardioLogs ECG Analysis Platform

Both tools are cloud-based, FDA-cleared, and claim HIPAA compliance. However, CardioLogs, as a Philips solution, explicitly offers EHR integration via Philips IntelliBridge Enterprise and ISO/IEC 27001 certified AWS hosting, indicating robust enterprise integration and security. Verily Study Watch faces an ongoing lawsuit regarding alleged BAA breaches, which, even if denied, introduces a potential risk factor for enterprise adoption concerning data security and compliance.

Innovation

Study Watch

Verily Study Watch demonstrates innovation in its continuous, multi-modal physiological data collection via a wearable device, pushing the boundaries of remote monitoring for clinical research with multiple sensors. CardioLogs innovates by applying deep neural networks to streamline and enhance the accuracy of ECG analysis across various devices, being the first FDA-cleared AI solution for ECG analysis, but Study Watch's approach to novel data acquisition is more foundational.

Support & Docs

Tie

Both companies, backed by large enterprises, offer accessible support resources. Philips Cardiologs provides in-platform support and general healthcare professional resources including technical documents. Verily offers a dedicated 'Support hub' with documentation, tutorials, and direct contact options with a stated response time for its platform users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform Study Watch
Product Name CardioLogs ECG Analysis Platform Study Watch
Company Cardiologs Technologies (now part of Philips) Verily Life Sciences
Primary Function Uses medical-grade AI and cloud technology for rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, aiding physicians in arrhythmia detection and diagnosis. Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform.
Core Analysis/Monitoring AI-Powered ECG Analysis (Deep Neural Networks), Automated Arrhythmia Detection (e.g., AFib, VT) Continuous physiological monitoring, Cloud-based data processing with algorithms and machine learning
Device/Data Source Compatibility Multi-Device Compatibility (Holter, smartwatches, ECG patches) Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), On-demand single-channel ECG
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Neurology, Sleep Medicine

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and Study Watch.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CardioLogs ECG Analysis Platform is designed for rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices to aid physicians in arrhythmia detection and diagnosis. In contrast, Verily Study Watch is a prescription-only, sensor-based wearable device primarily for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis.
CardioLogs ECG Analysis Platform analyzes ECG data that is uploaded from various compatible cardiac monitoring devices, such as Holter monitors, smartwatches, and ECG patches. The Verily Study Watch, on the other hand, is itself a wearable device equipped with multiple physiological sensors (including ECG, heart rate, and movement) that continuously collects and stores its own data.
CardioLogs ECG Analysis Platform is primarily used in Cardiology, Emergency Medicine, and Internal Medicine. Verily Study Watch is applicable to Cardiology, Neurology, and Sleep Medicine, reflecting its broader physiological monitoring capabilities for research.
Both tools have FDA clearance. CardioLogs is HIPAA compliant and uses ISO/IEC 27001 certified AWS servers for data encryption and secure hosting. Verily states its products are built to meet healthcare data protection standards and are designed to meet all applicable HIPAA requirements, though an ongoing lawsuit alleges HIPAA violations, which Verily denies.
CardioLogs ECG Analysis Platform offers integration with EHR systems. The Verily Study Watch uploads encrypted data to Verily's cloud platform for processing, and its data can be leveraged for research and potentially integrated into clinical care environments.
CardioLogs ECG Analysis Platform offers real-time monitoring and analysis of uploaded ECG data. The Verily Study Watch is designed for continuous physiological monitoring through its multiple sensors, providing long battery life for extended data collection.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.